Seroprevalence of varicella-zoster virus in Korea

Wonseok Choi, Ji Yun Noh, Joong Yeon Huh, Yu Mi Jo, Jacob Lee, Joon-Young Song, Woo Joo Kim, Hee-Jin Cheong

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Varicella-zoster virus (VZV) causes chickenpox and herpes zoster. Korea is assumed to have a high seroprevalence of VZV, although data are scant. A cross-sectional and age-stratified study was conducted to investigate the seroprevalence of VZV in different ages in the South Korean population. Four medical institutions were chosen in the southwestern area of Seoul in the vicinity of Gyeonggi-do. Serum samples were obtained at each institution from consenting patients during April-August, 2008. Anti-VZV IgG antibody was measured by an enzyme immunoassay. Of the 887 patients, 87.6% had anti-VZV IgG antibody. The prevalence of anti-VZV IgG antibody was 75% during the first 3 months after birth, but was only 13.6% 12 months after birth. Anti-VZV IgG antibody prevalence increased, first at 1-2 years of age, and then at 5-6 years of age. The seroprevalence rate exceeded 90% in subjects over 11 years of age. The results show that the seroprevalence of VZV is relatively high in the South Korean population. A study on the rate of varicella vaccination and the vaccine's efficacy in South Korea is warranted. J. Med. Virol. 82:2123-2126, 2010.

Original languageEnglish
Pages (from-to)2123-2126
Number of pages4
JournalJournal of Medical Virology
Volume82
Issue number12
DOIs
Publication statusPublished - 2010 Dec 1

Fingerprint

Human Herpesvirus 3
Seroepidemiologic Studies
Korea
Immunoglobulin G
Antibodies
Parturition
Chickenpox Vaccine
Republic of Korea
Chickenpox
Herpes Zoster
Immunoenzyme Techniques
Population
Vaccination
Serum

Keywords

  • Herpes zoster
  • Seroprevalence
  • Varicella
  • Varicella zoster virus

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology

Cite this

Seroprevalence of varicella-zoster virus in Korea. / Choi, Wonseok; Noh, Ji Yun; Huh, Joong Yeon; Jo, Yu Mi; Lee, Jacob; Song, Joon-Young; Kim, Woo Joo; Cheong, Hee-Jin.

In: Journal of Medical Virology, Vol. 82, No. 12, 01.12.2010, p. 2123-2126.

Research output: Contribution to journalArticle

@article{dd5ef4b1040c46a49add9ff22430e9ca,
title = "Seroprevalence of varicella-zoster virus in Korea",
abstract = "Varicella-zoster virus (VZV) causes chickenpox and herpes zoster. Korea is assumed to have a high seroprevalence of VZV, although data are scant. A cross-sectional and age-stratified study was conducted to investigate the seroprevalence of VZV in different ages in the South Korean population. Four medical institutions were chosen in the southwestern area of Seoul in the vicinity of Gyeonggi-do. Serum samples were obtained at each institution from consenting patients during April-August, 2008. Anti-VZV IgG antibody was measured by an enzyme immunoassay. Of the 887 patients, 87.6{\%} had anti-VZV IgG antibody. The prevalence of anti-VZV IgG antibody was 75{\%} during the first 3 months after birth, but was only 13.6{\%} 12 months after birth. Anti-VZV IgG antibody prevalence increased, first at 1-2 years of age, and then at 5-6 years of age. The seroprevalence rate exceeded 90{\%} in subjects over 11 years of age. The results show that the seroprevalence of VZV is relatively high in the South Korean population. A study on the rate of varicella vaccination and the vaccine's efficacy in South Korea is warranted. J. Med. Virol. 82:2123-2126, 2010.",
keywords = "Herpes zoster, Seroprevalence, Varicella, Varicella zoster virus",
author = "Wonseok Choi and Noh, {Ji Yun} and Huh, {Joong Yeon} and Jo, {Yu Mi} and Jacob Lee and Joon-Young Song and Kim, {Woo Joo} and Hee-Jin Cheong",
year = "2010",
month = "12",
day = "1",
doi = "10.1002/jmv.21917",
language = "English",
volume = "82",
pages = "2123--2126",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Seroprevalence of varicella-zoster virus in Korea

AU - Choi, Wonseok

AU - Noh, Ji Yun

AU - Huh, Joong Yeon

AU - Jo, Yu Mi

AU - Lee, Jacob

AU - Song, Joon-Young

AU - Kim, Woo Joo

AU - Cheong, Hee-Jin

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Varicella-zoster virus (VZV) causes chickenpox and herpes zoster. Korea is assumed to have a high seroprevalence of VZV, although data are scant. A cross-sectional and age-stratified study was conducted to investigate the seroprevalence of VZV in different ages in the South Korean population. Four medical institutions were chosen in the southwestern area of Seoul in the vicinity of Gyeonggi-do. Serum samples were obtained at each institution from consenting patients during April-August, 2008. Anti-VZV IgG antibody was measured by an enzyme immunoassay. Of the 887 patients, 87.6% had anti-VZV IgG antibody. The prevalence of anti-VZV IgG antibody was 75% during the first 3 months after birth, but was only 13.6% 12 months after birth. Anti-VZV IgG antibody prevalence increased, first at 1-2 years of age, and then at 5-6 years of age. The seroprevalence rate exceeded 90% in subjects over 11 years of age. The results show that the seroprevalence of VZV is relatively high in the South Korean population. A study on the rate of varicella vaccination and the vaccine's efficacy in South Korea is warranted. J. Med. Virol. 82:2123-2126, 2010.

AB - Varicella-zoster virus (VZV) causes chickenpox and herpes zoster. Korea is assumed to have a high seroprevalence of VZV, although data are scant. A cross-sectional and age-stratified study was conducted to investigate the seroprevalence of VZV in different ages in the South Korean population. Four medical institutions were chosen in the southwestern area of Seoul in the vicinity of Gyeonggi-do. Serum samples were obtained at each institution from consenting patients during April-August, 2008. Anti-VZV IgG antibody was measured by an enzyme immunoassay. Of the 887 patients, 87.6% had anti-VZV IgG antibody. The prevalence of anti-VZV IgG antibody was 75% during the first 3 months after birth, but was only 13.6% 12 months after birth. Anti-VZV IgG antibody prevalence increased, first at 1-2 years of age, and then at 5-6 years of age. The seroprevalence rate exceeded 90% in subjects over 11 years of age. The results show that the seroprevalence of VZV is relatively high in the South Korean population. A study on the rate of varicella vaccination and the vaccine's efficacy in South Korea is warranted. J. Med. Virol. 82:2123-2126, 2010.

KW - Herpes zoster

KW - Seroprevalence

KW - Varicella

KW - Varicella zoster virus

UR - http://www.scopus.com/inward/record.url?scp=78049395863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049395863&partnerID=8YFLogxK

U2 - 10.1002/jmv.21917

DO - 10.1002/jmv.21917

M3 - Article

VL - 82

SP - 2123

EP - 2126

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 12

ER -